Project dates: 2013-2017
The West Africa Regional HIV Pharmaceutical Management Information Dashboard is developed and implemented for fifteen focus West African countries for better management of HIV and AIDS commodities. The goal of the Dashboard is to capture, track, aggregate, and disseminate information about antiretroviral drugs (ARVs), rapid test kits (RTKs), and other HIV and AIDS commodities to support evidence-based decision making in the West Africa subregion. The Dashboard will assist focus countries and subregional organizations in improving forecasting, supply planning, and procurement to support the continuous availability of ARVs, RTKs, and other HIV- and AIDS-related commodities.
The goal of the OSPSIDA Dashboard is to capture, track, aggregate, and disseminate information about antiretroviral drugs (ARVs), rapid test kits (RTKs), and other HIV and AIDS commodities to support evidence-based decision making in the West Africa subregion. The Dashboard offers regional partners a platform through which they may easily share information on funding flows and stock-out risks. The data available on this platform will be used to inform decision making and assist in identifying solutions to mitigate risks in the short-, medium-, and long-term. This User Guide assists users to make entries into the OSPSIDA Dashboard smoothly. The user guide has step-by-step guidance on how to access the dashboard, enter information, and generate reports.
Deployment of the HIV and AIDS Commodity Management Tool OSPSIDA in Six Focus Countries in West and Central Africa: Benin, Burkina Faso, Cameroon, Guinea, Niger, and Togo
The availability and quality of HIV commodity, including antiretrovirals and HIV test kits, increases the demand for HIV care services and enables the scale-up of antiretroviral therapy. In West Africa and Central Africa, stock-outs often occurred because of poor coordination and information sharing among partners and lack of a reliable early warning system.
With funding from USAID West Africa and in collaboration with West African Health Organization and key stakeholders involved in the procurement and supply management at country and regional levels, SIAPS has provided supports to six countries in West and Central Africa: Benin, Burkina Faso, Cameroon, Guinea, Niger, and Togo. These countries will set up a web-based early warning system known as the HIV and AIDS Commodity Management Tool (OSPSIDA) to monitor HIV and AIDS commodities.
Transition of the HIV and AIDS Commodity Management Tool (OSPSIDA) to the West African Health Organization and Cameroon: Lessons Learned and Recommendations
USAID’s West African office asked SIAPS to provide support to six countries in the West and Central African region—Burkina Faso, Benin, Cameroon, Guinea, Niger, and Togo—to establish a web-based regional dashboard (OSPSIDA.org) that will create an early warning system (EWS) to monitor HIV and AIDS commodities and to detect and minimize the risk of stock-out in the focus countries.
In pursuit of this objective, and to ensure local ownership and long-term sustainability, the West African Health Organization (WAHO) has been involved since the project’s inception and has provided useful input during the design phase and official launch in Accra in April 2014. However, for the long-term sustainability of the dashboard and in an effort to support WAHO’s strategy of setting up security stock for West African countries, it is necessary to transfer the dashboard to WAHO’s Essential Medicines and Vaccines Program as its final home.
A strong pharmaceutical management system is critical for responding to and preventing public health emergencies. The US Agency for International Development (USAID)-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program, implemented by Management Sciences for Health (MSH), is helping four countries affected by Ebola—Sierra Leone, Guinea, Mali, and Benin—recover and rebuild essential drug management and delivery services and to increase their capacity and sustainability. The two-year project began in 2015.
Stakeholders Meeting on the Use of HIV and AIDS Pharmaceutical Management Information for Faster Decision Making
Alerts about stock-outs of life-saving medicines for antiretroviral therapy (ART) and treating opportunistic infections have been issued in a number of countries in West Africa (WA). Eight countries in the region have not only reported stock-outs of critical medications, but have also demonstrated a lack of capacity to identify and address the underlying causes of stock-outs or to generate accurate and reliable data for decision making.
To provide effective long-term solutions, the US Agency for International Development’s (USAID) West Africa office requested that the Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program provide support to six countries in the WA region. Based on information collected from the rapid situational analyses in five countries, SIAPS developed a regional dashboard to serves as an early warning indicators system (EWS) for monitoring HIV and AIDS commodities to detect and minimize the risk of stock-outs in six focus countries.
On April 20-21, 2015, SIAPS and WAHO co-facilitated a regional stakeholders meeting for representatives of National AIDS Control Programs (NACP), managers of Central Medical Stores, and pharmaceutical commodity managers from the WA region, as well as representatives from other organizations operating in the region
The West and Central African regions have a low HIV prevalence. Because of the low number of patients on ART and limited technical and financial support, these regions have experienced frequent stock-outs of ARVs posing a serious risk to patients on ART and increasing the risk of HIV drug resistance in the region. As a key step in addressing this challenge, the West Africa Regional Health Office of the US Agency for International Development is providing support through the Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program to address the recurring pharmaceutical supply management issues by supporting the regional coordination mechanism and the development and implementation of an early warning system (EWS) for antiretrovirals (ARVs) and HIV and AIDS related commodities.
As part of project startup, SIAPS conducted a situational analysis in Burkina Faso, Cameroon, Guinea, Niger, and Togo to gain an understanding of the current capacity for HIV and AIDS commodities management and supply. Also analyzed was the readiness of the HIV and AIDS commodities information management systems to provide the information necessary for routine monitoring of HIV and AIDS product availability in the region.
A Protocol for Rapid Situational Analysis of the HIV and AIDS Commodity Supply Chain in Seven Target West African Countries
As part of project startup, SIAPS will conduct a situational analysis of seven countries (Benin, Burkina Faso, Cameroon, Guinea, Mauritania, Niger, and Togo) to gain an understanding of the current capacity for HIV and AIDS commodities management and supply. The situational analysis will also assess the readiness of the HIV and AIDS commodities information management systems to provide the information necessary for routine monitoring of HIV and AIDS product availability in the region.
The findings from the situational analysis will inform the development of appropriate interventions that will bridge the gaps and serve as a basis for establishing a regional coordination mechanism for HIV/AIDS commodities management.
- The Use of Pharmaceutical Information for Decision Making in Namibia's National ART Program: Assessment Report
SIAPS conducted this assessment to determine the extent to which pharmaceutical information generated from the Electronic Dispensing Tool (EDT) and […]
The Directorate of Drugs and Medical Supplies (DDMS) plays a key role in providing technical guidance and setting strategic direction […]
- Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program Inventory of Key Technical Resources
The main purpose of this inventory is to serve as a reference to help stakeholders working in the pharmaceutical sector […]